Oxra-S 5/50

Oxra-S 5/50 is used for managing Type 2 diabetes in adults who require dual-action blood sugar control through a combination of Dapagliflozin (5mg) and Sitagliptin (50mg). This tablet works by addressing hyperglycemia through two complementary mechanisms: Dapagliflozin is an SGLT2 inhibitor that helps your kidneys remove excess glucose through urine, while Sitagliptin is a DPP-4 inhibitor that increases insulin release and decreases glucagon production when blood sugar is elevated. Patients comparing treatment options often explore Januvia 50mg (Sitagliptin) as a single-agent alternative, while others requiring additional metformin coverage consider Janumet XR CP (Sitagliptin/Metformin) for extended-release glucose control. Manufactured by Sun Pharmaceutical Industries Ltd, Oxra-S 5/50 offers a convenient once-daily regimen that addresses insulin deficiency and excess glucose retention simultaneously.

Dosage & How to Take Oxra-S 5/50

Take Oxra-S 5/50 exactly as prescribed by your healthcare provider, typically one tablet once daily in the morning with or without food. Swallow the tablet whole with water—do not crush, chew, or split it. Because Dapagliflozin works by increasing urinary glucose excretion, maintaining adequate hydration throughout the day is important. Your doctor may adjust your dosage based on blood sugar response, kidney function, and tolerance. If you miss a dose, take it as soon as you remember unless it's almost time for your next dose—never double up. Regular monitoring with OneTouch Ultra Test Strips helps track your glucose levels and treatment effectiveness. Store tablets at room temperature away from moisture and heat.

Is Oxra-S 5/50 Right for You?

Oxra-S 5/50 is appropriate for adults with Type 2 diabetes whose blood sugar is not adequately controlled with diet, exercise, and single-agent therapy. It is particularly beneficial for patients who need both improved insulin secretion and enhanced glucose elimination without relying solely on metformin-based combinations like Glycomet 250mg (Metformin). However, this medication is not suitable for Type 1 diabetes or diabetic ketoacidosis. Patients with severe kidney impairment (eGFR below 45 mL/min) should not use Dapagliflozin, and those with a history of pancreatitis should discuss risks with their doctor before starting Sitagliptin. Pregnant or breastfeeding women, individuals with frequent urinary tract infections, and those taking certain diuretics require careful medical evaluation. Always disclose your complete medication list and health history to ensure Oxra-S 5/50 fits safely into your diabetes management plan.

Buying Oxra-S 5/50 Online — USA, UK, Australia & Canada

SafeRxPills provides secure access to Oxra-S 5/50 for customers in Australia, the United Kingdom, the United States, and Canada with discreet 7-14 day shipping. All orders are dispensed from licensed facilities with full pharmaceutical tracking and quality assurance. We require a valid prescription to ensure safe, appropriate use of this combination diabetes medication. Our online platform offers transparent pricing, secure checkout, and dedicated customer support to assist patients managing chronic conditions. Whether you're newly diagnosed or optimizing your current diabetes regimen, SafeRxPills ensures reliable delivery and professional service across all four markets, helping you maintain consistent treatment without interruption.